Can scans and blood tests predict cancer treatment success?
NCT ID NCT07259915
Summary
This study aims to see if combining different types of medical scans (CT, MRI, PET) with a special blood test that detects tiny amounts of cancer DNA can predict how well a patient's head and neck cancer will respond to standard chemo-radiation treatment. Researchers will enroll 152 patients with specific types of advanced head and neck cancer who are scheduled to receive this treatment. The goal is to create a better prediction tool to help guide future care decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Henri Becquerel
Rouen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier Universitaire
Rouen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.